Total planned funding: $175,288,387
Allocations
Countries/Regions
India | $175,288,387 |
Organizational Types
Unknown | $76,703,088 |
NGO | $46,457,784 |
Own Agency | $23,464,718 |
University | $16,540,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,006,808 |
Host Country Government Agency | $1,610,200 |
FBO | $900,000 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $76,650,753 |
Prevention | $39,442,582 |
Care | $21,739,740 |
Management and Operations | $19,003,300 |
Testing | $7,336,458 |
Treatment | $6,687,762 |
Budget Codes
OHSS: Health Systems Strengthening | $48,416,817 |
HVSI: Strategic Information | $23,261,337 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,591,276 |
HVMS: Management and Operations | $19,003,300 |
HBHC: Care: Adult Care and Support | $14,553,668 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,448,510 |
HVCT: Testing: HIV Testing and Counseling | $7,336,458 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,547,226 |
HTXS: Treatment: Adult Treatment | $6,344,351 |
HLAB: Laboratory Infrastructure | $4,972,599 |
HKID: Care: Orphans and Vulnerable Children | $4,857,055 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $2,069,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,341,303 |
PDTX: Treatment: Pediatric Treatment | $319,934 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$75,655,599
Countries/Regions
USG Aggregated Agencies:
$11,518,288
Countries/Regions
FHI 360:
$11,190,654
Countries/Regions
Voluntary Health Services:
$10,040,000
Countries/Regions